Ultram for controlling pain after surgery

Ultram before and after surgery

The beauty of any drug classified as a painkiller is that it’s useful regardless whether the pain is the accident of injury or disease, or caused intentionally. So, from the moment medical treatment became more scientific, surgeons have been working on the best way of anesthetizing their patients and then controlling the pain when they have finished hacking away with knives and saws. For centuries, the most effective remedies came from the poppy. These were remarkable in distracting the mind from even the most horrific of injuries, but equally remarkable in the speed with which patients were addicted. So the search has been to find an effective painkiller with a reduced risk of addiction. In many ways, Ultram is the best developed so far. It’s a synthetic opioid, taking most of the opiate’s pain-killing ability, but with a smaller risk of dependence. Thus, in the post-operative environment, you give the maximum possible dosage in the expectation that, as soon as healing gets under way, you can begin reducing the dosage to keep the risk of dependence small.

New research

The most pleasing aspect of the scientific method is that it never assumes we have arrived at a perfect solution to a problem. But rather challenges orthodoxy to see whether it can be improved upon. In the case of the post-operative use of painkillers, recent research has moved to a different treatment strategy. The problem with the current model is that a high dosage is necessary to bring the concentration of Ultram up to effective levels quickly. The researchers speculated that if you began to give Ultram to a patient at low dosage two days before the operation, this would require less anesthetic and only a small increase in the dosage after surgery. In a reasonably comprehensive trial, the patients given Ultram before their operations made a significantly faster recovery because they recovered from the anesthetic feeling less pain. This improved their mood. They were quicker to get into rehabilitation and achieved mobility more quickly. Based on this research, the various national regulatory bodies are considering whether to advise doctors to change their practice standards. The idea of being able to make a faster recovery on a lower dosage of painkillers which are less addictive is attractive to all involved.